Ionis Pharmaceuticals (IONS) PT Raised to $69 at Citi
Tweet
Share
E-mailGet Alerts IONS Hot Sheet
Price: $60.92 +1.74%
Rating Summary:
17 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 31
Rating Summary:
17 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 31
Join SI Premium – FREE
Citi analyst David Lebowitz raised the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $69.00 (from $65.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barrick Is Said to Weigh Delaying North America Gold IPO to 2027 - Bloomberg
- GitLab Inc (GTLB) PT Raised to $55 at DA Davidson, Neutral Rating Maintained
- Google launches Gemini 3.8 Flash and a cybersecurity model variant
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Citi, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
